Disease block
G10-G14 – Systematrophien, die vorwiegend das Zentralnervensystem betreffen
- Chapter VI: Krankheiten des Nervensystems
6Decisions
21Patient groups
Added benefit by patient group
- Major2
- Considerable1
- Non-quantifiable4
- Not proven14
Diseases in this disease block
- G11 Hereditäre Ataxie 1 decision
- G12 Spinale Muskelatrophie und verwandte Syndrome 5 decisions
Decisions, newest first
Each decision lists only the patient groups coded with a disease in this disease block.
- 2025-12-18SkyclarysOmaveloxolonNot proven
- 2024-12-19QalsodyTofersenNon-quantifiable
- 2024-03-07EvrysdiRisdiplamNot proven: 3 of 3 patient groups
- 2021-11-04ZolgensmaOnasemnogen abeparvovecNot proven: 4 of 4 patient groups
- 2021-10-21EvrysdiRisdiplamNon-quantifiable: 2 of 6 patient groupsNot proven: 4 of 6 patient groups
- 2021-05-20SpinrazaNusinersenMajor: 2 of 6 patient groupsConsiderable: 1 of 6 patient groupsNon-quantifiable: 1 of 6 patient groupsNot proven: 2 of 6 patient groups
Data status: 2026-10-29